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A B S T R A C T
Diagnosing Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins (ACD/MPV) based on a genetic alteration in the FOXF1 gene, is complicated by the poor
understanding of the causal relation between FOXF1 variants and the ACD/MPV phenotype. Here, we report the generation of human iPSC lines from two ACD/MPV patients,
each carrying a different heterozygous FOXF1 mutation, which enables disease modeling for further research on the effect of FOXF1 variants in vitro. The iPSC lines were
generated from skin fibroblasts using the non-integrating Sendai virus. The lines expressed pluripotency genes, retained the heterozygous mutation and were capable of
trilineage differentiation.
Resource Table
Unique stem cell lines identifier EMC127i-A
EMC127i-B
EMC128i-A
Alternative names of stem cell lines EMC127i-A: ACD871C4
EMC127i-B: ACD871C8
EMC128i-A: ACD874C9
Institution Erasmus University Medical Center Rotterdam, The Netherlands
Contact information of distributor Robbert Rottier; r.rottier@erasmusmc.nl
Type of cell lines iPSC
Origin Human
Cell Source Skin fibroblasts
Clonality Clonal
Method of reprogramming CytoTune-iPS 2.0 Sendai reprogramming
Multiline rationale Two isogenic iPSC clones from ACD/MPV patient 1 and one iPSC clone from ACD/MPV patient 2.
Gene modification Yes
Type of modification Congenital, de novo
Associated disease Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins (ACD/MPV)
Gene/locus Patient 1: FOXF1; 16q24.1; Chr16(GRCh37): g.86544341C>G (c.166C>G)
Patient 2: FOXF1; 16q24.1; Chr16(GRCh37): g.86544428T>A (c.253T>A)
Method of modification N/A
Name of transgene or resistance N/A
Inducible/constitutive system N/A
Date archived/stock date EMC127i-A: 2019-5-1
EMC127i-B: 2019-4-25
EMC128i-A: 2019-5-28
Cell line repository/bank https://hpscreg.eu/cell-line/EMCi127-A
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1. Resource utility
The ACD/MPV patient specific iPSC lines are useful for disease
modeling to investigate the pathogenesis of ACD/MPV. The iPSC lines
will help to elucidate the effect of specific FOXF1 mutations on the
function of different cell types that are important during lung devel-
opment.
2. Resource details
Diagnosing congenital lung disorder Alveolar Capillary Dysplasia
with Misalignment of the Pulmonary Veins (ACD/MPV) based on a
genetic alteration in the FOXF1 gene, is complicated by the poor un-
derstanding of the causal relation between FOXF1 variants and the
ACD/MPV phenotype. Although several studies revealed a strong as-
sociation with mutations and copy number variations in the FOXF1
gene, an invasive lung biopsy is still necessary to confirm ACD/MPV
(Stankiewicz et al., 2009; Slot et al., 2018). Studies in mice confirmed
that FOXF1 is important in early lung development. However, rodent
knock-down models do not display all ACD/MPV features that are ob-
served in human patients (Mahlapuu et al., 2001). Unfortunately, there
is limited accessibility of patient samples, which complicates further
research on ACD/MPV and FOXF1 function in human. Here, we report
the generation of human iPSC lines from two ACD/MPV patients, each
carrying a different heterozygous FOXF1 mutation, which is a major
contribution to the research field by enabling the investigation of
FOXF1 function in vitro.
The iPSC lines were generated at the Erasmus MC iPS Core Facility
from patient derived skin fibroblasts. From patient 1, who carried
FOXF1 mutation c.166C>G, we generated two isogenic iPSC clones.
From patient 2, who carried FOXF1 mutation c.253T>A (Sen et al.,
2013), we generated one iPSC clone (Table 1:). All lines showed iPSC
morphology and expression of pluripotent markers NANOG, OCT4 and
SSEA4 (Fig. 1A). In addition, quantitative RT-PCR revealed increased
expression of NANOG and OCT3/4 compared to patients’ skin fibro-
blasts, and similar expression as control line HuES9 (Cowan et al.,
2004) (Fig. 1B). Sanger sequencing confirmed the presence of the het-
erozygous mutations (Fig. 1C) and SNP arrays confirmed the absence of
major copy number variations other than balanced translocations
(Fig. 1D). Further, the numbers of SNP counts verified the identity of
the iPSC lines (Suppl. Fig. 1B). All clones were mycoplasma free (Suppl.
Fig. 1C) and able to differentiate into the three germ layers as shown by
expression of trilineage markers (Fig. 1E) (Table 2:).
3. Materials and methods
3.1. Ethical approval
iPSC lines were generated from anonymized fibroblasts that were
previously isolated from skin tissues of ACD/MPV patients. The re-
search proposal was approved by the Daily Board of the Medical Ethics
Committee (METC) Erasmus University Medical Center Rotterdam, The
Netherlands.
3.2. Generation and culture of human iPSC lines
Skin fibroblasts were reprogrammed using the CytoTune™-iPS 2.0
Sendai Reprogramming Kit (Invitrogen) according to the manufac-
turer's instructions. After reprogramming, single colonies were col-
lected and maintained on Matrigel (Corning) plates in mTeSR™1
(STEMCELL Technologies) at 37 °C with 5% CO2. Every four days (at
80–90% confluency), the cells were passaged in an 1:6 ratio. The first
five passages were done by means of mechanical passaging, all fol-
lowing passages were done using ReLeSR™ (Stem Cell Technologies).
The absence of Sendai virus was confirmed by quantitative RT-PCR
(Suppl. Fig. 1A) at passage 7 (ACD871C4-C8) and passage 9
(ACD874C9). As negative and positive controls, RNA of non-transduced
skin fibroblasts and skin fibroblasts 7 days after transduction were used.
3.3. Immunofluorescence staining
iPS cells were cultured on Geltrex (ThermoFisher Scientific) coated
4-well chamber slides (Sarstedt) and fixed for 15 min with 4% PFA at
room temperature. Thereafter, cells were permeabilized with 0.1%
Triton-X100 for 10 min and blocked with 1% BSA/0.05% Tween 20/
PBS for 30 minTable 1: at room temperature. The cells were incubated
overnight at 4 °C with primary antibodies (Table 3) diluted in blocking
buffer. The next day, the cells were washed and incubated with fluor-
ophore-tagged secondary antibodies (Table 3) for 1 h at room tem-
perature. Finally, the cells were stained with DAPI and imaged with a
Leica SP5 confocal microscope.
3.4. Quantitative gene expression analysis
RNA was isolated from iPS cells, skin fibroblasts and HuES9 cells
using the ReliaPrep™ RNA Cell Miniprep System (Promega) and cDNA
was prepared from mRNA using SuperScript™ II Reverse Transcriptase
kit (Invitrogen). qPCR was performed with the CFX96 C1000 Thermal
Cycler (Bio-rad) using SYBR Green premix (Bio-rad) and the primers
listed in Table 3. mRNA expression was normalized to GAPDH.
3.5. Genotyping of the human iPSC lines
Genomic DNA was isolated from iPS cells (passage 12 for
ACD871C4-C8 and passage 16 for ACD874C9) and fibroblasts (passage
7) using the QIAamp DNA Mini Kit (Qiagen) and tested for copy
number variations with GSAMD24 v1 Illumina Infinium SNP array
700k (Illumina). Data was analyzed with GenomeStudio software
(IIllumina) and visualized using Nexus Copy Number 9.0
(BioDiscovery). To confirm iPSC identities, we compared the number of
SNPs found in iPSC lines and patient fibroblasts with R software. To
assure the presence of the heterozygous FOXF1 mutations, the regions
of interest were amplified with PCR using M13 tailed primers (Table 3),
followed by Sanger sequencing with the 3730xl DNA Analyzer (Applied
Biosystems, ThermoFisher Scientific). The PCR was performed with the
Biometra TAdvanced Thermocycler (Westburg) and consisted of 35
cycles of the following steps: 30 s at 94 °C, 30 s at 60 °C and 90 s at
72 °C.
3.6. Trilineage differentiation
In vitro trilineage differentiation was induced with the STEMdiff™
Trilineage Differentiation Kit (STEMCELL Technologies) according to
manufacturer's instructions. In brief, cells were plated in a single cell
suspension on Geltrex coated 4-well chamber slides (Sarstedt). The cells
were daily fed with either ectoderm, mesoderm or endoderm specific
medium. After five (mesoderm and endoderm) or seven (ectoderm)
days, the cells were fixed with 4% PFA and used for immuno-
fluorescence staining.
Table 1.
Summary of lines.
iPSC line names Gender Age Ethnicity Genotype of
locus
ACD871C4 Male Newborn Caucasian c.166C>G ACD/MPV
ACD871C8 Male Newborn Caucasian c.166C>G ACD/MPV
ACD874C9 Male Newborn Caucasian c.253T>A ACD/MPV
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Fig. 1. ⁎
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3.7. Mycoplasma detection
Cell cultures were tested for mycoplasma contamination with the
MycoAlert™ Mycoplasma Detection Kit (Lonza), according to manu-
facturer's instructions.
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